Semaglutide, the active ingredient in Ozempic, is a GLP-1 receptor agonist
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: A post-treatment analysis of a randomised placebo-controlled trial
It is not a supplement, not a drug, but a functional food made from sugarcane stalk (with the sugar removed during processing ), natural skins, and resistant starch containing grains, all of which are packed full of key micronutrients
(Seoul.) 39 , 111 (2024)
February 29, 2024 [17] Clinical Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment) [Internet]